Differential Effects of Three Canonical Toxoplasma Strains on Gene Expression in Human Neuroepithelial Cells

ABSTRACT Strain type is one of the key factors suspected to play a role in determining the outcome of Toxoplasma infection. In this study, we examined the transcriptional profile of human neuroepithelioma cells in response to representative strains of Toxoplasma by using microarray analysis to characterize the strain-specific host cell response. The study of neural cells is of interest in light of the ability of Toxoplasma to infect the brain and to establish persistent infection within the central nervous system. We found that the extents of the expression changes varied considerably among the three strains. Neuroepithelial cells infected with Toxoplasma type I exhibited the highest level of differential gene expression, whereas type II-infected cells had a substantially smaller number of genes which were differentially expressed. Cells infected with type III exhibited intermediate effects on gene expression. The three strains also differed in the individual genes and gene pathways which were altered following cellular infection. For example, gene ontology (GO) analysis indicated that type I infection largely affects genes related to the central nervous system, while type III infection largely alters genes which affect nucleotide metabolism; type II infection does not alter the expression of a clearly defined set of genes. Moreover, Ingenuity Pathways Analysis (IPA) suggests that the three lineages differ in the ability to manipulate their host; e.g., they employ different strategies to avoid, deflect, or subvert host defense mechanisms. These observed differences may explain some of the variation in the neurobiological effects of different strains of Toxoplasma on infected individuals.

[1]  U. Lopes,et al.  Novel role for the double‐stranded RNA‐activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Satoru Otani,et al.  Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders , 2010, Biological Psychiatry.

[3]  Terry J. Smith,et al.  Testes and brain gene expression in precocious male and adult maturing Atlantic salmon (Salmo salar) , 2010, BMC Genomics.

[4]  R. E. Everts,et al.  Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPARγ signaling as potential mechanism for the negative relationships between immune response and lipid metabolism , 2009, BMC Genomics.

[5]  Tyrone D. Cannon,et al.  Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. , 2009, Microbes and infection.

[6]  Yang O. Zhao,et al.  Disruption of the Toxoplasma gondii Parasitophorous Vacuole by IFNγ-Inducible Immunity-Related GTPases (IRG Proteins) Triggers Necrotic Cell Death , 2009, PLoS pathogens.

[7]  T. Tully,et al.  ben Functions with Scamp during Synaptic Transmission and Long-Term Memory Formation in Drosophila , 2009, The Journal of Neuroscience.

[8]  Charlotte E. Egan,et al.  Toxoplasma gondii Prevents Chromatin Remodeling Initiated by TLR-Triggered Macrophage Activation1 , 2009, The Journal of Immunology.

[9]  D. Staines,et al.  Postulated Role of Vasoactive Neuropeptide-Related Immunopathology of the Blood Brain Barrier and Virchow-Robin Spaces in the Aetiology of Neurological-Related Conditions , 2009, Mediators of inflammation.

[10]  R. Schwarz,et al.  The dual origin of Toxoplasma gondii N-glycans. , 2008, Biochemistry.

[11]  Liliane Schoofs,et al.  Discovery of a cholecystokinin-gastrin-like signaling system in nematodes. , 2008, Endocrinology.

[12]  C. Beckers,et al.  N-linked glycosylation of proteins in the protozoan parasite Toxoplasma gondii. , 2008, Molecular and biochemical parasitology.

[13]  F. Pineda,et al.  Kinetic modeling of Toxoplasma gondii invasion. , 2007, Journal of Theoretical Biology.

[14]  D. Weinberger,et al.  Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia , 2007, Molecular Psychiatry.

[15]  Yuji Kamiya,et al.  Global Analysis of DELLA Direct Targets in Early Gibberellin Signaling in Arabidopsis[W] , 2007, The Plant Cell Online.

[16]  S. Weis,et al.  Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology , 2007, Journal of Neuroscience Methods.

[17]  J. Boothroyd,et al.  Toxoplasma gondii Dysregulates IFN-γ-Inducible Gene Expression in Human Fibroblasts: Insights from a Genome-Wide Transcriptional Profiling1 , 2007, The Journal of Immunology.

[18]  J. Boothroyd,et al.  Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors , 2007, Proceedings of the National Academy of Sciences.

[19]  Naama Barkai,et al.  Strategy of Transcription Regulation in the Budding Yeast , 2007, PloS one.

[20]  J. Boothroyd,et al.  Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue , 2007, Nature.

[21]  B. Spengler,et al.  The fine structure of continuous human neuroblastoma lines SK-N-SH, SK-N-BE(2), and SK-N-MC , 1981, In Vitro.

[22]  L. Garcia Parasitic Infections in the Compromised Host , 2007 .

[23]  J. Ajioka,et al.  Toxoplasma : molecular and cellular biology , 2007 .

[24]  M. El Gazzar HMGB1 modulates inflammatory responses in LPS-activated macrophages , 2007, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

[25]  M. E. Gazzar HMGB1 modulates inflammatory responses in LPS-activated macrophages , 2007, Inflammation Research.

[26]  R. Yolken,et al.  Altered transcriptional activity of human endogenous retroviruses in neuroepithelial cells after infection with Toxoplasma gondii. , 2006, The Journal of infectious diseases.

[27]  Lu Zhang,et al.  Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays , 2006, BMC Genomics.

[28]  J. Boothroyd,et al.  Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. , 2005, Trends in parasitology.

[29]  M. Stanford,et al.  The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells , 2005, Journal of Neuroimmunology.

[30]  P. Illés,et al.  VIP enhances both pre‐ and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells , 2004, British journal of pharmacology.

[31]  John M Davis,et al.  Physical health monitoring of patients with schizophrenia. , 2004, The American journal of psychiatry.

[32]  S. Akira,et al.  Production of IL-12 by Macrophages Infected with Toxoplasma gondii Depends on the Parasite Genotype1 , 2004, The Journal of Immunology.

[33]  B. Butcher,et al.  Toxoplasma gondii Interferes with Lipopolysaccharide-Induced Mitogen-Activated Protein Kinase Activation by Mechanisms Distinct from Endotoxin Tolerance1 , 2004, The Journal of Immunology.

[34]  M. Lakso,et al.  Identification of Genes Regulated by Memantine and MK-801 in Adult Rat Brain by cDNA Microarray Analysis , 2004, Neuropsychopharmacology.

[35]  J. Borst,et al.  CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool , 2003, The Journal of experimental medicine.

[36]  Damien Chaussabel,et al.  Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. , 2003, Blood.

[37]  S. Cliffe Toxoplasmosis: a comprehensive clinical guide , 2003 .

[38]  S. Parmley,et al.  Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. , 2003, The Journal of infectious diseases.

[39]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[40]  Z. Šmahel,et al.  BMC Infectious Diseases BioMed Central Research article BMC 22002, Infectious Diseases , 2002 .

[41]  L. Sibley,et al.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  V. Tekiel,et al.  Changes in the mouse sciatic nerve action potential after epineural injection of sera from Trypanosoma cruzi infected mice , 2001, Parasite immunology.

[43]  J. Webster,et al.  Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. , 2001, Microbes and infection.

[44]  J. Boothroyd,et al.  Unusual abundance of atypical strains associated with human ocular toxoplasmosis. , 2001, The Journal of infectious diseases.

[45]  Peter F. Johnson,et al.  Toxoplasma gondii Tachyzoites Inhibit Proinflammatory Cytokine Induction in Infected Macrophages by Preventing Nuclear Translocation of the Transcription Factor NF-κB1 , 2001, The Journal of Immunology.

[46]  I. D. Manger,et al.  Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells* , 2001, The Journal of Biological Chemistry.

[47]  M. Yaniv,et al.  The mammalian Jun proteins: redundancy and specificity , 2001, Oncogene.

[48]  J. P. Webster,et al.  Fatal attraction in rats infected with Toxoplasma gondii , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[49]  T. Boone,et al.  Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Church,et al.  Systematic determination of genetic network architecture , 1999, Nature Genetics.

[51]  P. Kelly,et al.  Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. , 1998, Endocrine reviews.

[52]  L. Sibley,et al.  Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis , 1997, Journal of clinical microbiology.

[53]  J. Montoya,et al.  Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. , 1996, The Journal of infectious diseases.

[54]  L. Sibley,et al.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. , 1995, The Journal of infectious diseases.

[55]  R. Meli,et al.  Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis. , 1995, Pathologie-biologie.

[56]  R. V. van Lier,et al.  Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. , 1995, Journal of immunology.

[57]  R. Weichselbaum,et al.  Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Sica,et al.  Functional changes of the sciatic nerve in mice chronically infected with Trypanosoma cruzi. , 1993, Medicina.

[59]  R. Genta,et al.  Parasitic Infections in the Compromised Host , 1988 .

[60]  J. Ellenberg,et al.  Toxoplasmosis: Maternal and Pediatric Findings in 23,000 Pregnancies , 1988, Pediatrics.

[61]  G. L. Noel,et al.  Human prolactin and growth hormone release during surgery and other conditions of stress. , 1972, The Journal of clinical endocrinology and metabolism.

[62]  A. Frantz,et al.  Human Prolactin: 24-Hour Pattern with Increased Release doring Sleep , 1972, Science.